GlobalRPh Cardiovascular Risk and Advanced Lipid Analyzer – Updated

GlobalRPh Cardiovascular Risk and Advanced Lipid Analyzer | Version 2.0 What does an LDL-C of 80 mg/dL tell you? Two patients return with the same LDL-C. One started at 200 mg/dL, the other at 100 mg/dL. The updated analyzer puts the untreated value back in view and

Testosterone therapy- A clearer clinical review

GlobalRPh clinical tools | For healthcare professionals Recently updated: Version 1.7 Testosterone therapy.A clearer clinical review.

Polypharmacy at the End of Life: Why Are So Many Patients Still Taking Statins and Bisphosphonates?

Evidence-based clinical review Polypharmacy at the End of Life: Why Are So Many Patients Still Taking Statins and Bisphosphonates? A prognosis- and goals-based approach to preventive medications, with important exceptions for recent ASCVD, high fracture risk, and active cancer indications Estimated

Continuous Glucose Monitoring Beyond Insulin: Evidence, OTC Systems, and Data Interpretation for Family Medicine

Evidence-based clinical review Continuous Glucose Monitoring Beyond Insulin Evidence, OTC Systems, and Data Interpretation for Family Medicine A practical framework for selecting professional, prescription, or over-the-counter CGM and converting an ambulatory glucose profile into safe clinical decisions Estimated reading time: 15 minutes

Blood-Based Colorectal Cancer Screening in Family Practice: Where Shield Fits Among FIT, Stool DNA, and Colonoscopy

Evidence-based clinical review Blood-Based Colorectal Cancer Screening in Family Practice: Where Shield Fits Among FIT, Stool DNA, and Colonoscopy A practical framework for average-risk adults who remain unscreened or decline preferred modalities Abstract Background: The U.S. Food

Triple Therapy for COPD: Who Benefits, Who Is at Risk for Pneumonia, and Who May Be Overtreated?

Evidence-based clinical review Triple Therapy for COPD: Who Benefits, Who Is at Risk for Pneumonia, and Who May Be Overtreated? A phenotype- and exacerbation-based approach to adding, continuing, or withdrawing inhaled corticosteroids Estimated reading time: 16 minutes

Multi-Cancer Early Detection Blood Tests in Family Practice: Clinical Promise, False Positives, and the Risks of Premature Adoption

Evidence-based clinical review Multi-Cancer Early Detection Blood Tests in Family Practice: Clinical Promise, False Positives, and the Risks of Premature Adoption Updated: September 2, 2026 | Estimated reading time: 15 minutes Abstract Background Multi-cancer early detection

Outpatient Community-Acquired Pneumonia in 2026: Are We Still Treating Too Broadly?

Evidence-based clinical review Outpatient Community-Acquired Pneumonia in 2026: Are We Still Treating Too Broadly? Updated: September 2, 2026 | Estimated reading time: 15 minutes Abstract Background Outpatient community-acquired pneumonia (CAP) is a common setting for

CGRP-Targeted Migraine Prevention as a First-Line Option: A Family Medicine Prescribing Framework

Evidence-based clinical review CGRP-Targeted Migraine Prevention as a First-Line Option: A Family Medicine Prescribing Framework Reconciling AHS and ACP guidance, selecting oral, injectable, and infusion therapies, and monitoring the updated 2026 safety warnings Estimated reading time: 17 minutes

Shorter Antibiotic Courses: How Short Is Too Short?

Evidence-based clinical review Shorter Antibiotic Courses: How Short Is Too Short? A syndrome-specific guide to finding the shortest effective duration in adults Updated: September 2, 2026 | Estimated reading time: 15 minutes Abstract Background

GlobalRPh Cardiovascular Risk and Advanced Lipid Analyzer – Updated